High Plasma Fibrinogen is Correlated With Poor Response to Trastuzumab Treatment in HER2 Positive Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High Plasma Fibrinogen is Correlated With Poor Response to Trastuzumab Treatment in HER2 Positive Breast Cancer

Published:2015-02 Issue:5 Volume:94 Page:e481
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Liu Yu-Lin,Lu Qing,Liang Ji-Wei,Xia Yu,Zhang Wei,Hu Bao-Quan,Shang Fang-Fang,Ji You-Ran,Wang Jun,Wang Qiang,Liang Bing

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference37 articles.

1. Monoclonal antibody therapy of cancer.;Adams;Nat Biotechnol,2005

2. Timed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocyte-macrophage colony-stimulating factor-secreting breast tumor vaccine: a chemotherapy dose-ranging factorial study of safety and immune activation.;Emens;J Clin Oncol,2009

3. Enteral immuno-enhanced diets with arginine are safe and beneficial for patients early after esophageal cancer surgery.;Aiko;Dis Esophagus,2008

4. Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescape.;Ferris;J Clin Oncol,2010

5. Cetuximab-related tumor lysis syndrome in metastatic colon carcinoma.;Krishnan;J Clin Oncol,2008

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hemostasis parameters as prognostic biomarkers in gynecological cancer patients;Obstetrics, Gynecology and Reproduction;2023-05-22

2. Hemostasis and cancer: Impact of haemostatic biomarkers for the prediction of clinical outcomes in patients with cancer;Journal of Thrombosis and Haemostasis;2022-12

3. Circulating Proteins Associated with Response and Resistance to Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer;Cancers;2022-02-21

4. Predictive value of hemoglobin, platelets, and D-dimer for the survival of patients with stage IA1 to IIA2 cervical cancer: a retrospective study;Journal of International Medical Research;2021-12

5. Hemostatic Biomarkers and Cancer Prognosis: Where Do We Stand?;Seminars in Thrombosis and Hemostasis;2021-08-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3